Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy

Title: The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
Authors: Athanasiou, D; Aguila, M; Bellingham, J; Li, W; McCulley, C; Reeves, PJ; Cheetham, ME
Source: Progress in Retinal and Eye Research , 62 pp. 1-23. (2018)
Publication Year: 2018
Collection: University College London: UCL Discovery
Subject Terms: CRISPR; Endocytosis; GPCR; Mutation; Neurodegeneration; Protein misfolding; Protein traffic; Proteostasis; Retinal dystrophy; Rhodopsin; Therapy
Description: Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding condition, retinitis pigmentosa (RP). Over 150 different mutations in rhodopsin have been identified and, collectively, they are the most common cause of autosomal dominant RP (adRP). Mutations in rhodopsin are also associated with dominant congenital stationary night blindness (adCSNB) and, less frequently, recessive RP (arRP). Recessive RP is usually associated with loss of rhodopsin function, whereas the dominant conditions are a consequence of gain of function and/or dominant negative activity. The in-depth characterisation of many rhodopsin mutations has revealed that there are distinct consequences on the protein structure and function associated with different mutations. Here we categorise rhodopsin mutations into seven discrete classes; with defects ranging from misfolding and disruption of proteostasis, through mislocalisation and disrupted intracellular traffic to instability and altered function. Rhodopsin adRP offers a unique paradigm to understand how disturbances in photoreceptor homeostasis can lead to neuronal cell death. Furthermore, a wide range of therapies have been tested in rhodopsin RP, from gene therapy and gene editing to pharmacological interventions. The understanding of the disease mechanisms associated with rhodopsin RP and the development of targeted therapies offer the potential of treatment for this currently untreatable neurodegeneration.
Document Type: article in journal/newspaper
File Description: text
Language: English
Relation: https://discovery.ucl.ac.uk/id/eprint/10025810/1/The%20molecular%20and%20cellular%20basis%20of%20rhodopsin%20retinitis%20pigmentosa%20reveals%20potential%20strategies%20for%20therapy.pdf; https://discovery.ucl.ac.uk/id/eprint/10025810/
Availability: https://discovery.ucl.ac.uk/id/eprint/10025810/1/The%20molecular%20and%20cellular%20basis%20of%20rhodopsin%20retinitis%20pigmentosa%20reveals%20potential%20strategies%20for%20therapy.pdf; https://discovery.ucl.ac.uk/id/eprint/10025810/
Rights: open
Accession Number: edsbas.4CB7400
Database: BASE